 | Up a level |
Fagnan, Alexandre; Bagger, Frederik Otzen; Piqué-Borràs, Maria-Riera; Ignacimouttou, Cathy; Caulier, Alexis; Lopez, Cécile K; Robert, Elie; Uzan, Benjamin; Gelsi-Boyer, Véronique; Aid, Zakia; Thirant, Cécile; Moll, Ute; Tauchmann, Samantha; Kurtovic-Kozaric, Amina; Maciejewski, Jaroslaw; Dierks, Christine; Spinelli, Orietta; Salmoiraghi, Silvia; Pabst, Thomas; Shimoda, Kazuya; ... (2020). Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. Blood, 136(6), pp. 698-714. American Society of Hematology 10.1182/blood.2019003062
Waibel, Michaela; Solomon, Vanessa S; Knight, Deborah A; Ralli, Rachael A; Kim, Sang-Kyu; Banks, Kellie-Marie; Vidacs, Eva; Virely, Clemence; Sia, Keith C S; Bracken, Lauryn S; Collins-Underwood, Racquel; Drenberg, Christina; Ramsey, Laura B; Meyer, Sara C.; Takiguchi, Megumi; Dickins, Ross A; Levine, Ross; Ghysdael, Jacques; Dawson, Mark A; Lock, Richard B; ... (2013). Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors. Cell reports, 5(4), pp. 1047-1059. Cell Press 10.1016/j.celrep.2013.10.038
